Treatment Advances in HCV: Improving Disease Identification and Management in the Federal Healthcare System
1.0 AMA PRA Category 1 Credit™
This publication can help clinicians who care for patients within the federal healthcare system gain a better understanding of recommendations for HCV screening, current therapies for disease management, and emerging treatments.
Sponsored by Med-IQ. This activity is approved for AMA PRA Category 1 Credit™.